Should we continue or discontinue inflammatory bowel disease medication in patients with COVID-19? Hayashi Y, Nakase H, Hisamatsu T. Gastroenterology 2022 Mar 11. pii: S0016-5085(22)00239.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hayashi Y, Nakase H, Hisamatsu T. Should we continue or discontinue inflammatory bowel disease medication in patients with COVID-19? Gastroenterology 2022 Mar 11. pii: S0016-5085(22)00239.
PMID: 35288110